{"id":"W4409344692","doi":"10.3389/or.2025.1564642","title":"Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action","year":2025,"lang":"en","type":"review","venue":"Oncology Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Fulvestrant; Tamoxifen; Breast cancer; Raloxifene; Selective estrogen receptor modulator; Anastrozole; Estrogen receptor; Toremifene; Aromatase; Cancer; Oncology; Pharmacology; Exemestane; Internal medicine; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005826373,0.0007883041,0.001152098,0.002285751,0.0002429371,0.0007788007,0.000767454,0.0008065896,0.005422519],"category_scores_gemma":[0.0009465457,0.0002675734,0.0008365031,0.002078849,0.0002451134,0.0009445017,0.0004679947,0.001397053,0.002001538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004855199,"about_ca_system_score_gemma":0.001002666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001174796,"about_ca_topic_score_gemma":0.002537226,"domain_scores_codex":[0.9997743,0.00004313282,0.00004004296,0.00003567545,0.00008726757,0.00001960877],"domain_scores_gemma":[0.9996418,0.0001845924,0.00005193739,0.000007797607,0.00009017626,0.00002360346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001026186,0.000078959,0.0001253487,0.03288109,0.0001272854,0.0001255005,0.00006136468,0.0002885433,0.001040003,0.001900341,0.03465768,0.9286112],"study_design_scores_gemma":[0.00003498697,0.0001781971,0.0006536349,0.01071337,0.0002876897,0.0009027243,0.00005065909,0.00008629087,0.0003180004,0.0008542666,0.9859034,0.00001694687],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009202051,0.9988172,0.00005332793,0.00017059,0.0001226893,0.000007151329,0.00002480911,0.000005456553,0.0007067582],"genre_scores_gemma":[0.00035129,0.9989144,0.0001181059,0.0001608107,0.00007860197,0.000007245446,0.00003235844,0.000001056948,0.0003362439],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005422519,"threshold_uncertainty_score":0.0181402,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05362469868518655,"score_gpt":0.4212260659151388,"score_spread":0.3676013672299523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}